All In Biotech

Free tool

FAERS Monitor: Azilect

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021641 or its brand name (Azilect, Rasagiline Mesylate). Reports on generic versions are filed under their own applications.

Reports

11,264

Serious

7,507

67% of reports

Hospitalization

3,676

Death reported

1,255

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fall1,093
  • hallucination986
  • dyskinesia784
  • drug ineffective772
  • dizziness675
  • tremor663
  • death638
  • confusional state561
  • parkinson^s disease543
  • gait disturbance536
  • somnolence515
  • nausea501
  • fatigue482
  • constipation433
  • insomnia378

Reports by year received

View as table
YearReports
20067
200766
2008138
200995
2010271
2011268
2012303
2013437
2014423
2015590
2016692
2017897
2018912
20191,045
20201,057
2021911
2022813
2023521
2024629
2025634
2026555

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,895 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
dyskinesiaSignal78436.734.326,725
hallucinationSignal98624.723.322,224
tremorSignal6637.57.03,733
confusional stateSignal5616.56.02,617
fallSignal1,0936.15.84,768
gait disturbanceSignal5365.24.81,847
somnolenceSignal5154.84.41,549
constipationSignal4333.73.4863
insomniaSignal3782.72.4392
dizzinessSignal6752.52.4637
death6381.41.370
nausea5011.21.114
fatigue4821.21.110
drug ineffective7721.11.07
parkinson^s disease5430.00.01,012,566

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.